1. Home
  2. SSRM vs PRAX Comparison

SSRM vs PRAX Comparison

Compare SSRM & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SSR Mining Inc.

SSRM

SSR Mining Inc.

HOLD

Current Price

$31.85

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$368.71

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSRM
PRAX
Founded
1946
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
SSRM
PRAX
Price
$31.85
$368.71
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$32.74
$572.13
AVG Volume (30 Days)
3.2M
380.0K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
243.41
N/A
EPS
N/A
N/A
Revenue
$1,629,637,000.00
N/A
Revenue This Year
$56.48
N/A
Revenue Next Year
$4.31
$7,758.26
P/E Ratio
N/A
N/A
Revenue Growth
63.68
N/A
52 Week Low
$15.99
$37.25
52 Week High
$36.52
$386.66

Technical Indicators

Market Signals
Indicator
SSRM
PRAX
Relative Strength Index (RSI) 62.26 63.13
Support Level $28.41 $285.26
Resistance Level $33.66 N/A
Average True Range (ATR) 1.31 18.47
MACD 0.71 7.02
Stochastic Oscillator 85.52 83.40

Price Performance

Historical Comparison
SSRM
PRAX

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: